Kathleen Hemschoot
Family · Atlantic Highlands, NJNPI 1891132684
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 450 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 19.0% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 450 payments — averaging $19.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$2K
- AstraZeneca$2K
- AbbVie$1K
- GSK$755
- Amgen$683
- Lilly USA, LLC$425
- plus $2K from 24 others
What the payments were for
- Food & beverage$8,829100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 97 | $1,674 |
| AstraZeneca | 50 | $1,663 |
| AbbVie | 67 | $1,247 |
| GSK | 41 | $755 |
| Amgen | 24 | $683 |
| Lilly USA, LLC | 29 | $425 |
| Boehringer Ingelheim | 17 | $323 |
| Pfizer | 22 | $320 |
| Kowa Pharmaceuticals America, Inc. | 20 | $271 |
| Bayer | 10 | $226 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $168 |
| E.r. Squibb & Sons, L.L.C. | 5 | $159 |
| Amarin Pharma, Inc. | 11 | $141 |
| Merck | 7 | $94 |
| Johnson & Johnson(2 entities) | 5 | $89 |
| Idorsia Pharmaceuticals US Inc | 6 | $88 |
| Exact Sciences | 4 | $87 |
| Astellas Pharma US Inc | 3 | $62 |
| BD | 1 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $57 |
| Phathom Pharmaceuticals, Inc. | 3 | $43 |
| Paratek Pharmaceuticals, Inc. | 3 | $40 |
| IBSA Pharma Inc. | 2 | $27 |
| Acadia Pharmaceuticals Inc | 2 | $27 |
| Cumberland Pharmaceuticals, Inc. | 1 | $21 |
| Renalytix AI, Inc. | 1 | $20 |
| Seqirus USA Inc | 1 | $19 |
| Novartis | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,829 in reported general payments places this provider in the 95th percentile of 2,692 family providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 38 | $41,420 |
| EliquisApixaban | 47 | $33,678 |
| FarxigaDapagliflozin Propanediol | 26 | $23,431 |
| RybelsusSemaglutide | 12 | $18,964 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $13,336 |
| Tresiba Flextouch U-100Insulin Degludec | 16 | $11,056 |
| XareltoRivaroxaban | 12 | $9,621 |
| Rosuvastatin Calcium | 87 | $1,143 |
| SynthroidLevothyroxine Sodium | 20 | $1,071 |
| Alprazolam | 204 | $1,022 |
| Levothyroxine Sodium | 81 | $967 |
| Pantoprazole Sodium | 57 | $953 |
| Atorvastatin Calcium | 88 | $752 |
| Losartan Potassium | 82 | $743 |
| Amlodipine Besylate | 109 | $685 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $1,674 | $60,38350 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $1,663 | $36,76740 claims |
| PfizerEliquis | $320 | $33,67847 claims |
| Johnson & JohnsonXarelto | $89 | $9,62112 claims |
| AbbVieSynthroid | $1,247 | $1,07120 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,692 family providers in New Jersey.
Other family in Atlantic Highlands
- Alyssa TedescoAtlantic Highlands$9K
- Jennifer DemaioMorristown$412K
- Kara TrlicaCranbury$186K
- Nicole BauerParamus$161K
- China BattistaWall Township$142K
- Nancy EisenbergerVoorhees$82K
- Jennifer AbitabiloGlen Ridge$54K
- Megan FiloramoMorristown$53K
- Shawn DenningToms River$29K
- Kimberly ClementeEatontown$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.